Samuel C. Blackman Insider Profile

4 Followers
Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, holds 2.09M shares in Day One Biopharmaceuticals (Ticker: DAWN).
tipranks
Samuel C. Blackman

Samuel C. Blackman
Day One Biopharmaceuticals (DAWN)
HEAD OF R&D

Not Ranked
Samuel C. Blackman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34M
100.00%
A breakdown of Samuel C. Blackman's holdings

Insider Roles

Day One Biopharmaceuticals
(DAWN)
HEAD OF R&D
Roles that Samuel C. Blackman holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Samuel C. Blackman

Samuel C. Blackman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Day One Biopharmaceuticals
Nov 08, 2024
HEAD OF R&D
Uninformative Sell
180.26K
$34.19M
Samuel C. Blackman has not reported any informative transactions for DAWN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 03, 2021
Uninformative Buy
$0.00
-
$0.00
Nov 17, 2022
Uninformative Buy
$17.73K
-
$21.78
Feb 17, 2023
Uninformative Buy
$38.10K
-
$19.54
May 17, 2023
Uninformative Buy
$26.82K
-
$13.72
Aug 17, 2023
Uninformative Buy
$26.95K
-
$13.79
List of latest transactions for each holding click on a transaction to see Samuel C. Blackman's performance on stock

Samuel C. Blackman insider profile FAQ

What is the percentage of profitable transactions made by Samuel C. Blackman?
The percentage of profitable transactions made by Samuel C. Blackman is ―.
    What is the average return per transaction made by Samuel C. Blackman?
    The average return per transaction made by Samuel C. Blackman is ―.
      What stocks does Samuel C. Blackman hold?
      Samuel C. Blackman holds: DAWN stocks.
        What was Samuel C. Blackman’s latest transaction?
        Samuel C. Blackman latest transaction was an Uninformative Sell of $180.26K.
          What was Samuel C. Blackman's most profitable transaction?
          Samuel C. Blackman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Samuel C. Blackman's role in Day One Biopharmaceuticals?
            Samuel C. Blackman's role in Day One Biopharmaceuticals is HEAD OF R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.